ACI Archean Chemical Industries Q4 FY26 results (Jan–Mar 2026) and concall
Archean Chemical reported a mixed Q4 and full year FY26, with overall revenue growth but significant pressure on profitability due to increased logistics costs, muted industrial salt demand, and challenges in scaling up new businesses. While core bromine performance remained resilient with strong realization growth and production recovery, the company is focused on strategic initiatives including semiconductor project execution, new product development in derivatives, and cost reduction to navigate the volatile external environment.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 9.3%, net profit down 48.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 238 | 243 | 322 | 279 | 221 −7% | 250 +3% | 292 −9% |
| EBITDA | 76 | 84 | 90 | 83 | 65 −14% | 59 −30% | 54 −40% |
| Net profit | 22 | 56 | 58 | 52 | 38 +73% | 34 −39% | 30 −48% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
